Dr. Matthew D Hellmann MD
Hematologist-Oncologist | Hematology & Oncology
300 E 66TH ST NEW YORK NY, 10065Rating
2/5
About
I am a medical oncologist who specializes in the care of patients with lung cancers, particularly non small-cell lung cancers. I am dedicated to identifying better treatments for people with all stage ...
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Nivolumab Monotherapy for First-Line Treatment of Advanced Non-Small-Cell Lung Cancer.
- Pneumonitis in Patients Treated With Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy.
- ORAL01.03: CheckMate 012: Safety and Efficacy of First-Line Nivolumab and Ipilimumab in Advanced NSCLC: Topic: Medical Oncology.
- Antibody-mediated thyroid dysfunction during T-cell checkpoint blockade in patients with non-small-cell lung cancer.
- 'Genotype/immunotype' correlations in resected NSCLC.
- Thinking Critically About Classifying Adverse Events: Incidence of Pancreatitis in Patients Treated With Nivolumab + Ipilimumab.
- Reply to M. Nishino et al.
- Prognostic impact of TTF-1 expression in patients with stage IV lung adenocarcinomas.
- Expression of PD-L1 and other immunotherapeutic targets in thymic epithelial tumors.
- Making It Personal: Neoantigen Vaccines in Metastatic Melanoma.
- Nivolumab Versus Docetaxel in Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer: Two-Year Outcomes From Two Randomized, Open-Label, Phase III Trials (CheckMate 017 and CheckMate 057).
- Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors.
Clinical Trials
- Pembrolizumab (Immunotherapy Drug) in Combination With Guadecitabine and Mocetinostat (Epigenetic Drugs) for Patients With Advanced Lung Cancer.
- A Personal Cancer Vaccine (NEO-PV-01) w/ Nivolumab for Patients With Melanoma, Lung Cancer or Bladder Cancer
- Phase 1/1b Study to Evaluate the Safety and Tolerability of CPI-444 Alone and in Combination With Atezolizumab in Advanced Cancers
- Evaluate the Mediators of Sensitivity and Resistance to Nivolumab Plus Ipilimumab in Patients With Advanced NSCLCs
Treatments
- Lung Cancer, Immunotherapy, Clinical Trials
Dr. Matthew D Hellmann MD's Practice location
Practice At Massachusetts General Hospital 55 Fruit Street
Massachusetts General Hospital 55 Fruit Street -Boston, MA 02114Get Direction
Dr. Matthew D Hellmann MD's reviews
Write ReviewPatient Experience with Dr. Hellmann
Recommended Articles
![]()
Tips for Young Adult Lymphoma Survivors to Make the Most of RecoveryIt is extremely difficult to reenter the world and normal life after battling lymphoma. Recovery is much more than the body's physical battle, but how to balance emotions and relationships as well.However, there are specific tools that can assist in adapting back into a life that may seem...
![]()
What Specialists Treat Multiple Myeloma?If you suffer from multiple myeloma, which a rare form of blood cancer, one of the most crucial decisions you will have to make is choosing a doctor who specializes in multiple myeloma. A hematologist-oncologist is the specialist you need who will manage your cancer throughout the cycle of...
![]()
Lymphoma, the Persistence of Inspirational Women, and the Power of LanguageEach year, Leukemia and Blood Cancer New Zealand (LBC) sponsors their Blood Cancer Patient Forum. They invite speakers to bring them news about such topics as treatment advances and management of cancer from a fully developed psycho-social perspective. Essentially, they dish up good old-fashioned...
- Treatment Options of Multiple Myeloma
A team led by a consultant haematology specialist takes care of you if you are a multiple myeloma patient. The team discusses your situation and suggests the best treatment for you, but you will finally decide.It may be paramount to compile a list of questions which you will ask the specialist...
![]()
The Lymphoma Research Foundation Announces Partnership with the Annals of LymphomaThe Lymphoma Research Foundation (LRF) is the nation’s largest non-profit organization for lymphoma research, and they just announced their partnership with the Annals of Lymphoma (AOL). This was all revealed in September during Blood Cancer Awareness Month. LRF is devoted to exclusively funding...
- Can Multiple Myeloma be Asymptomatic?
Early treatment for persons suffering from multiple myeloma that is asymptomatic may not be beneficial. The initial stages for multiple myeloma do not show symptoms, and this is known as being asymptomatic.The treatment for persons with asymptomatic multiple myeloma should be deferred up to when the...
Nearby Providers
![]()
Dr. Elan Diamond M.D.525 E 68th St New York NY 10065![]()
Dr. Ana Maria luisa Molina MD1275 York Ave New York NY 10065![]()
Dr. Scott Tagawa MD525 E 68th St New York NY 10065![]()
Dr. David Kaminetzky M.D.1275 York Ave New York NY 10065![]()
Dr. Yelena Y Janjigian MD1275 York Ave New York NY 10065![]()
Dr. Matthew J Matasar M.D.1275 York Ave New York NY 10065
Nearest Hospitals
MASSACHUSETTS EYE AND EAR INFIRMARYl
243 CHARLES STREET BOSTON MA 2114SHRINERS' HOSPITAL FOR CHILDREN - BOSTON, THEl
51 BLOSSOM STREET BOSTON MA 2114TUFTS MEDICAL CENTERl
800 WASHINGTON STREET BOSTON MA 2111